# Allegro MicroSystems Inc. (ALGM) — Financial Analysis

**Exchange:** NASDAQ  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-05-28  
**Tier:** Free primer (step 2 of 19)  
**Sibling pages:** /stocks/ALGM/thesis · /stocks/ALGM/memo

## Financial Snapshot

---
title: "Step 04 — Financial Snapshot & Quality (incl. Adversarial Sweep)"
ticker: ALGM
company: "Allegro MicroSystems, Inc."
source: coverage-next-full
created: 2026-05-28
step: "04"
---

### Step 04 — Financial Snapshot & Quality
#### Allegro MicroSystems, Inc. (ALGM)

> **No transcripts used.** Quality assessment is grounded in 10-K MD&A, 10-Q footnotes, proxy disclosures, and published adversarial commentary.

---

#### 1. Five-Year Financial Snapshot

| ($M except %, EPS) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|-------|--------|--------|--------|--------|--------|
| Revenue | 768.7 | 973.7 | 1,049.4 | 725.0 | 890.1 |
| Revenue YoY% | n/a | +26.7% | +7.8% | -30.9% | +22.8% |
| Gross Profit | 407.5 | 546.1 | 574.5 | 321.5 | 412.0 |
| Gross Margin | 53.0% | 56.1% | 54.8% | 44.3% | 46.3% |
| Operating Income | 136.7 | 203.3 | 196.2 | (19.8) | 18.5 |
| Operating Margin | 17.8% | 20.9% | 18.7% | (2.7%) | 2.1% |
| Net Income | 119.4 | 187.4 | 152.7 | (73.0) | (14.9) |
| EPS Diluted | 0.62 | 0.97 | 0.78 | (0.39) | (0.08) |
| Operating CF | 156.1 | 193.2 | 181.7 | 61.9 | 163.1 |
| FCF | 86.2 | 113.4 | 56.9 | 22.0 | 124.9 |
| CapEx | (69.9) | (79.8) | (124.8) | (40.0) | (38.2) |
| SBC | n/a | n/a | 42.5 | 41.9 | 47.9 |

Source: SEC XBRL [S1], StockAnalysis [S2]

---

#### 2. Earnings Quality Assessment

##### GAAP vs. Non-GAAP Reconciliation Gap

| Line item | FY2026 GAAP | FY2026 Non-GAAP | Gap | Comment |
|-----------|------------|------------------|------|---------|
| Gross profit | $412.0M | ~$439.5M | $27.5M | Driven by COGS amortization + SBC |
| Operating income | $18.5M | ~$117M | $98.5M | SBC ($48M) + amortization ($31M) + restructuring (~$15M) + CEO transition (~$5M) |
| Net income | ($14.9M) | ~$100M | $115M | Plus tax adjustment |
| EPS diluted | ($0.08) | ~$0.54 | $0.62 | |

**Key takeaway:** The GAAP-Non-GAAP gap is structural (driven by Crocus amortization, which runs through ~FY2029) plus dilution-laden SBC. Both are real economic costs. Non-GAAP is a defensible comparison metric for now, but investors should not extrapolate it as "true" earnings without discounting SBC.

##### SBC Treatment
- SBC of $47.9M = 5.4% of revenue in FY2026 (cycle-elevated; FY2024 was 4.0%).
- SBC is recurring; should be expensed in any valuation.
- Per-share dilution: ~1.6% per year net of modest buyback.

##### Working Capital
| Period | DSO | DIO | DPO | CCC (days) |
|--------|-----|-----|-----|------------|
| FY2024 | 56 | 110 | 38 | 128 |
| FY2025 | 65 | 145 | 45 | 165 |
| FY2026 | 58 | 125 | 42 | 141 |

Inventory days expanded in FY2025 (cycle-driven destock) and have come down in FY2026. CCC remains elevated vs. peers (MLX ~90 days, IFNNY ~100 days), reflecting auto-IC long lead times.

##### Cash Conversion (FCF / Net Income)
| Period | FCF/NI |
|--------|--------|
| FY2022 | 72% |
| FY2023 | 60% |
| FY2024 | 37% (capex spike) |
| FY2025 | nm (NI negative) |
| FY2026 | nm (NI negative) |

FCF generation is decoupling from GAAP earnings because of amortization. Look at non-GAAP NI: FY2026 ~$100M, FCF $125M → conversion 125% (working-capital release tailwind in recovery year).

---

#### 3. Capital Structure (FY2026 Balance Sheet)

| Item | $M |
|------|----|
| Cash & equivalents | 168.8 |
| Total debt | 305.9 |
| **Net debt** | **137.1** |
| Goodwill | 203.3 |
| Other intangibles | 238.7 |
| Total assets | 1,416 |
| Shareholders' equity | 956.5 |
| Net debt / FY2026 non-GAAP EBITDA (~$180M) | 0.76x |
| Total debt / equity | 32% |

- Net debt manageable; deleveraging trajectory (FY2025 $248M → FY2026 $137M).
- Goodwill + intangibles = $442M = **31% of total assets** = **46% of equity**. Impairment risk if Crocus revenue ramp disappoints. Latent tail risk flagged in Step 06.
- Retained earnings deeply negative (-$68.5M FY2026) due to FY2025 Sanken buyback ($870M cash repurchase). Doesn't impair operations but limits flexibility.

---

#### 4. ADVERSARIAL RESEARCH SWEEP (Mandatory)

Comprehensive review of public adversarial / skeptical sources.

##### Short Reports
- **Bear Cave Substack (2023):** Detailed Sanken/Polar Semiconductor related-party concerns. Key claims:
  - Sanken Electric (then ~50% owner) is also a customer and operator of Polar Semiconductor JV (Sanken 70% / Allegro 30%); wafer pricing set via related-party agreements.
  - Polar Semi shifted to losses in FY2023.
  - Polar CEO sat on Allegro's board — conflict of interest.
  - Allegated risk of value-transfer from Allegro to Sanken via wafer pricing.
- **Status:** Partially mitigated. Sanken ownership reduced to ~32.5% via July 2024 buyback. Board composition revised. But Polar Semiconductor JV remains intact, and Allegro is still exposed to JV wafer pricing decisions.

##### Class Actions / Investigations
- **None disclosed.** SEC has not initiated investigation. No securities class actions filed. The Bear Cave report did not trigger enforcement action.

##### onsemi Hostile Bid
- onsemi submitted **unsolicited acquisition proposals**: $34.50/share (Sept 2024), raised to $35.10/share (Feb 2025).
- Allegro board **unanimously rejected** the proposals on April 14, 2025 — citing inadequate price and risk to xEV/data-center pipeline.
- onsemi withdrew the bid.
- **Interpretation:** Strategic asset quality validated (large competitor wanted it). But also signals vulnerability — ALGM has not been a "natural acquirer" and could be approached again.

##### Management Turnover
- CEO Michael Doogue (since IPO 2020) replaced by Vineet Nargolwala in **Feb 2025**, during the downcycle.
- Doogue compensation ~$11M in FY2025 (a loss year) — governance red flag flagged by analysts and Bear Cave.
- Doogue continues to sell shares via trust post-transition (~$1.4M sale in May 2026) — modest but not constructive.

##### Customer Concentration / Disputes
- No customer >10% in FY2026 (Sanken largest at ~8–9%).
- No major customer disputes disclosed.

##### Restatements / Internal Controls
- No material restatements in 2024–2026.
- PwC audit clean — no going concern opinion.
- 404 internal control attestation clean.

##### Whistleblower / Press Coverage
- No whistleblower complaints disclosed.
- Press coverage largely positive on the onsemi rejection; mixed on Sanken governance.

##### Adversarial Sweep Summary
**Material risks identified:**
1. Sanken/Polar related-party complex (governance / pricing transparency) — **partially mitigated**.
2. Goodwill/intangibles impairment risk on Crocus ($442M on B/S) — **latent but not triggered**.
3. CEO transition + departed CEO selling — **modest, not red flag**.
4. China revenue concentration + tariff exposure — **ongoing**.

**No fraud-like red flags.** Earnings quality is reasonable; GAAP-non-GAAP gap is structural and disclosed. The principal adversarial concern is governance (Sanken), which has improved but is not resolved.

---

#### 5. Earnings Quality Score (Scaled 1–5)

| Factor | Score | Comment |
|--------|-------|---------|
| Revenue recognition | 5 | Standard ASC 606; no unusual policies |
| Inventory accounting | 4 | FIFO; reasonable provisioning; cycle-driven swings |
| Accruals quality | 4 | Working capital normalizing |
| SBC discipline | 3 | Elevated at 5.4% revenue |
| Tax transparency | 4 | Standard semiconductor effective rate disclosure |
| Related-party transparency | 3 | Sanken/Polar dynamics complex but disclosed |
| Audit quality | 5 | PwC, clean opinion |
| Restatement history | 5 | None |
| **Overall** | **4.1 / 5** | Above-average earnings quality with one structural governance asterisk |

---

#### 6. Source Index

| ID | Source | Retrieved |
|----|--------|-----------|
| S1 | SEC EDGAR XBRL Company Facts (CIK 0000866291) | 2026-05-27 |
| S2 | StockAnalysis financials (cached) | 2026-05-27 |
| S3 | FY2026 10-K MD&A | 2026-05-27 |
| S4 | Bear Cave Substack (2023) | 2026-05-27 |
| S5 | onsemi acquisition press releases, board responses | 2026-05-27 |
| S6 | DEF 14A 2025 (governance) | 2026-05-27 |
| S7 | Q4 FY2026 8-K earnings release reconciliation | 2026-05-27 |

## Deeper Financial Analysis

The fundamental tier ($1.00) adds 8 dimensions not included here:

- Revenue Breakdown — segment revenue, geographic mix, product-line margins
- Financial Trends — QoQ momentum, leading indicators, inflection points
- Balance Sheet — debt structure, dilution risk, working capital dynamics
- Capital Allocation — ROIC, buyback cadence, reinvestment efficiency
- Earnings Analysis — beats/misses, guidance vs actuals, transcript highlights
- Competitive Positioning — market share, pricing power, peer benchmarks
- Industry Context — TAM, sector tailwinds/headwinds, regulatory backdrop

**API endpoint:** GET /api/v1/research/ALGM/fundamental

## Navigation

- Overview: /stocks/ALGM
- Financials (this page): /stocks/ALGM/financials
- Thesis: /stocks/ALGM/thesis
- Investment Memo: /stocks/ALGM/memo
- Coverage universe: /stocks